Work

A NKG2D-based CAR-T therapy in a multinational phase I dose escalation and expansion study targeting multiple solid and hematologic tumor types.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.tps3093

Authors: Bikash Verma, Philippe Georges Aftimos, Ahmad Awada, Jean-Pascal H. Machiels, Jason B. Brayer, David A Sallman, Tessa Kerre, Kunle Odunsi, Caroline Lonez, David Edward Gilham, Frederic Lehmann

Institutions: Institut Jules Bordet, Université Libre de Bruxelles, Cliniques Universitaires Saint-Luc, UCLouvain, Moffitt Cancer Center, Ghent University Hospital, Roswell Park Comprehensive Cancer Center, Celyad (Belgium)

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2786931232

Cites:

Cited by: 4

Related to: 10